It makes sense to buy these solid stocks when their shares dip. The three pharmaceutical companies all offer dividends with above-average yields. Pfizer (NYSE:PFE), Bristol Myers Squibb (NYSE:BMY), and Johnson & Johnson (NYSE:JNJ) are huge pharmaceutical companies that offer attractive dividends. Another thing they have in common is they may all be underpriced, making now a good time to buy their stocks.
Take a quick look at their forward price-to-earnings (P/E) ratios, which range from Johnson & Johnson's low 16.5 to the really low 11.2 for Pfizer and 7.9 for Bristol Myers Squibb. Compare those numbers to the pharmaceutical average of 34.05, and you can see why I think now may be a good time to go shopping.
Source: Motley Fool
Related Articles:
Dividend Growth Stocks News
3 Rock-Solid Healthcare Dividend Stocks Now on Sale
Posted by D4L | Saturday, November 27, 2021 | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.